Genitourinary cancers: molecular determinants for personalized therapies

Roberta Mazzucchelli, Silvia Gasparrini, Andrea B. Galosi, Francesco Massari, Maria Rosaria Raspollini, Marina Scarpelli, Antonio Lopez-Beltran, Liang Cheng, Rodolfo Montironi

Research output: Contribution to journalEditorial

1 Citation (Scopus)

Abstract

Recent insights and emerging strategies for individualized therapeutic approaches in patients with genitourinary (GU) cancers are based on patient's genomic and cancer's molecular profiles. This depends on the significant advances made in molecular biology technologies, such as next-generation sequencing and whole-exome sequencing. The rise of such novel techniques has grayly increased our knowledge on cancer cell biology and development, thus allowing to identify complex abnormalities at the genomic level. These findings have paved the way toward what is called precision medicine, thus providing healthcare from an individual perspective in patients with GU tumors.

Original languageEnglish (US)
Pages (from-to)107-109
Number of pages3
JournalUrologia
Volume83
Issue number3
DOIs
StatePublished - Sep 26 2016

Fingerprint

Urogenital Neoplasms
Exome
Neoplasms
Precision Medicine
Cell Biology
Molecular Biology
Therapeutics
Technology
Delivery of Health Care

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Mazzucchelli, R., Gasparrini, S., Galosi, A. B., Massari, F., Raspollini, M. R., Scarpelli, M., ... Montironi, R. (2016). Genitourinary cancers: molecular determinants for personalized therapies. Urologia, 83(3), 107-109. https://doi.org/10.5301/uro.5000187

Genitourinary cancers : molecular determinants for personalized therapies. / Mazzucchelli, Roberta; Gasparrini, Silvia; Galosi, Andrea B.; Massari, Francesco; Raspollini, Maria Rosaria; Scarpelli, Marina; Lopez-Beltran, Antonio; Cheng, Liang; Montironi, Rodolfo.

In: Urologia, Vol. 83, No. 3, 26.09.2016, p. 107-109.

Research output: Contribution to journalEditorial

Mazzucchelli, R, Gasparrini, S, Galosi, AB, Massari, F, Raspollini, MR, Scarpelli, M, Lopez-Beltran, A, Cheng, L & Montironi, R 2016, 'Genitourinary cancers: molecular determinants for personalized therapies', Urologia, vol. 83, no. 3, pp. 107-109. https://doi.org/10.5301/uro.5000187
Mazzucchelli R, Gasparrini S, Galosi AB, Massari F, Raspollini MR, Scarpelli M et al. Genitourinary cancers: molecular determinants for personalized therapies. Urologia. 2016 Sep 26;83(3):107-109. https://doi.org/10.5301/uro.5000187
Mazzucchelli, Roberta ; Gasparrini, Silvia ; Galosi, Andrea B. ; Massari, Francesco ; Raspollini, Maria Rosaria ; Scarpelli, Marina ; Lopez-Beltran, Antonio ; Cheng, Liang ; Montironi, Rodolfo. / Genitourinary cancers : molecular determinants for personalized therapies. In: Urologia. 2016 ; Vol. 83, No. 3. pp. 107-109.
@article{56be7dab3dfb435ab59d2bb5bddd5bd3,
title = "Genitourinary cancers: molecular determinants for personalized therapies",
abstract = "Recent insights and emerging strategies for individualized therapeutic approaches in patients with genitourinary (GU) cancers are based on patient's genomic and cancer's molecular profiles. This depends on the significant advances made in molecular biology technologies, such as next-generation sequencing and whole-exome sequencing. The rise of such novel techniques has grayly increased our knowledge on cancer cell biology and development, thus allowing to identify complex abnormalities at the genomic level. These findings have paved the way toward what is called precision medicine, thus providing healthcare from an individual perspective in patients with GU tumors.",
author = "Roberta Mazzucchelli and Silvia Gasparrini and Galosi, {Andrea B.} and Francesco Massari and Raspollini, {Maria Rosaria} and Marina Scarpelli and Antonio Lopez-Beltran and Liang Cheng and Rodolfo Montironi",
year = "2016",
month = "9",
day = "26",
doi = "10.5301/uro.5000187",
language = "English (US)",
volume = "83",
pages = "107--109",
journal = "Urologia",
issn = "0391-5603",
publisher = "Wichtig Publishing",
number = "3",

}

TY - JOUR

T1 - Genitourinary cancers

T2 - molecular determinants for personalized therapies

AU - Mazzucchelli, Roberta

AU - Gasparrini, Silvia

AU - Galosi, Andrea B.

AU - Massari, Francesco

AU - Raspollini, Maria Rosaria

AU - Scarpelli, Marina

AU - Lopez-Beltran, Antonio

AU - Cheng, Liang

AU - Montironi, Rodolfo

PY - 2016/9/26

Y1 - 2016/9/26

N2 - Recent insights and emerging strategies for individualized therapeutic approaches in patients with genitourinary (GU) cancers are based on patient's genomic and cancer's molecular profiles. This depends on the significant advances made in molecular biology technologies, such as next-generation sequencing and whole-exome sequencing. The rise of such novel techniques has grayly increased our knowledge on cancer cell biology and development, thus allowing to identify complex abnormalities at the genomic level. These findings have paved the way toward what is called precision medicine, thus providing healthcare from an individual perspective in patients with GU tumors.

AB - Recent insights and emerging strategies for individualized therapeutic approaches in patients with genitourinary (GU) cancers are based on patient's genomic and cancer's molecular profiles. This depends on the significant advances made in molecular biology technologies, such as next-generation sequencing and whole-exome sequencing. The rise of such novel techniques has grayly increased our knowledge on cancer cell biology and development, thus allowing to identify complex abnormalities at the genomic level. These findings have paved the way toward what is called precision medicine, thus providing healthcare from an individual perspective in patients with GU tumors.

UR - http://www.scopus.com/inward/record.url?scp=85027500173&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027500173&partnerID=8YFLogxK

U2 - 10.5301/uro.5000187

DO - 10.5301/uro.5000187

M3 - Editorial

C2 - 27338983

AN - SCOPUS:85027500173

VL - 83

SP - 107

EP - 109

JO - Urologia

JF - Urologia

SN - 0391-5603

IS - 3

ER -